Tweetovi

Blokirali ste korisnika/cu @BU_HSM

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @BU_HSM

  1. proslijedio/la je Tweet
    3. velj

    February 26: Don’t miss discussing how large scale data analytics might help us identify and examine trends. RSVP today!

    Poništi
  2. proslijedio/la je Tweet
    prije 11 sati

    "It really depends on how much the manufacturers of these products are impacted, both in terms of the factories themselves & also among the workers in those factories" explains ’ potential impact on US drug supply w/

    Poništi
  3. 2. velj
    Poništi
  4. 1. velj
    Poništi
  5. proslijedio/la je Tweet
    30. sij

    You can watch videos on our initiative, our response to the opioid epidemic, rising drug prices + more on ’s channel!

    Poništi
  6. proslijedio/la je Tweet
    30. sij

    New: IHSIP & ’s spoke with about the ’ potential impact on the US drug supply.

    Poništi
  7. Poništi
  8. proslijedio/la je Tweet
    29. sij

    New: This January, a group of CEOs and industry leaders published a co-signed “New Commitment” to center patient needs and conduct ethical business. Our experts weighed in.

    Poništi
  9. 28. sij

    Dean’s Speaker Series - now

    Poništi
  10. 28. sij

    Today! HSM - Great event! See you at 5pm!

    Poništi
  11. proslijedio/la je Tweet
    28. sij
    Poništi
  12. 28. sij

    ‘The time to worry is now’: The coronavirus in China could threaten pharma’s ingredient sourcing via

    Poništi
  13. 27. sij

    Tomorrow. Great event for all HSM (students and alums)

    Poništi
  14. proslijedio/la je Tweet
    23. sij

    New: lends context to ’ discussion of a new collaboration between hospitals and insurers to produce generic drugs.

    Poništi
  15. proslijedio/la je Tweet
    21. sij

    Next week: Rekha Ramesh of and join moderator to discuss “Transformative : Perspectives on Treatment Access & Pricing”. Drop by the Auditorium at 5pm on the 28th to attend:

    Poništi
  16. proslijedio/la je Tweet
    21. sij

    The 340B drug discount program has been a source of controversy, with the pharmaceutical industry claiming that it's one of the main drivers of rising healthcare spending.

    Poništi
  17. proslijedio/la je Tweet

    STAT OF THE WEEK: Some candidates emphasized generic vs. brand name drugs during the discussion on high drug prices in the Iowa Though 86% of Medicaid prescriptions were for generics in '17, brand name drugs still made up 79% of drug spending.

    Poništi
  18. proslijedio/la je Tweet

    : The U.S. Supreme Court court's decision to reject the expedited review means legal questions surrounding the will persist through the 2020 election.

    Poništi
  19. 21. sij

    Envisioning a Better US Health Care System for All: Health Care Delivery and Payment System ... -

    Poništi
  20. 21. sij

    Apple working on preventative healthcare technology, CEO Cook reveals -

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·